NASDAQ:CMRA - Nasdaq - US20037C1080 - Common Stock - Currency: USD
WOBURN, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company...
WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced it appointed Dorothy Clarke to its board of directors.
– Final stage of technical evaluation near completion in Comera’s research collaboration with Regeneron, a leading U.S. biotechnology company – – Expanded...
It's time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning.
Pre-market stock movers are a hot topic worth checking out on Wednesday and we have all the latest news happening this morning!
WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Some of the most promising penny stocks can have multi-bagger potential over th...
These are just a few of the most promising penny stocks to consider as we head into the final months of the year.
Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous...
– Advanced to final stage of technical evaluation in Comera’s research collaboration with Regeneron, a leading U.S. biotechnology company – – Received...
WOBURN, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation...
Life sciences company Comera Life Sciences Holdings (CMRA) said on Tuesday that it is set to complete a $4.1M private placement of shares, and accompanying warrants.